<DOC>
	<DOC>NCT00756743</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of multiple ascending doses of PF-04802540 administered orally to healthy adult subjects.</brief_summary>
	<brief_title>Multiple Dose Safety Study of PF-04802540 in Healthy Volunteers</brief_title>
	<detailed_description>Evaluation of safety and pharmacokinetics</detailed_description>
	<criteria>Males or females of nonchildbearing capacity aged 21 to 55 years inclusive at screening. Body mass index in the range of 18 to 30 kg/m2 and body weight&gt;45 kg. Healthy as determined by the investigator on the basis of screening evaluation. Use of prescription or nonprescription drugs Any condition possibly affecting drug absorption</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>54 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>PF-04802540 multiple dose safety study</keyword>
</DOC>